Application

EIA/RIA (kd by liquid phase RIA for heparin is approximately

1.0 x 10-11 M.) Suggested concentration 1-10 µg/mL.

Inhibits the formation of heparin accelerated thrombin-antithrombin complex formation in vitro.

Optimal working dilutions must be determined by end user.

Research CategoryCell Structure

Detect Heparin using this Anti-Heparin Antibody, clone A7.10 validated for use in ELISA, RIA.

Research Sub CategoryECM Proteins

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Format: Purified

Purified immunoglobulin. Liquid in 0.02M PB + 0.25M NaCl, pH 7.6 with 0.1% Sodium azide.

Specificity

Reacts with mouse heparin. Cross reacts with dextran sulfate by EIA. Also shows some cross reactivity to DNA and heparan sulfate.

Storage and Stability

Maintain at 2-8°C.